Danaher Clocks 6% Jump In Q3 Sales, Improved Profitability

Loading...
Loading...
  • Danaher Corp (NYSE: DHR) has logged Q3 FY22 adjusted EPS of $2.56, up 7% Y/Y, surpassing the estimate of $2.26.
  • Sales increased 6% to $7.66 billion, with 10% non-GAAP core and 8.5% non-GAAP base business core revenue growth, beating the $7.17 billion estimate.
  • Operating cash flow reached $2 billion. Non-GAAP free cash flow reached $1.7 billion.
  • The gross margin compressed slightly from 60.3% to 59.8%, and the operating margin improved from 18.1% a year ago to 26.3%.
  • CEO Rainer M. Blair said, "Our growth was broad-based across all three segments, a testament to the durability and attractive end-market positioning of the franchises that comprise Danaher."
  • Outlook: For Q4 FY22, the company anticipates non-GAAP base business core revenue growth to be in the high-single-digit percent range. 
  • For FY22, the company is increasing its expectation for non-GAAP core revenue growth to the high-single-digit percent range, which includes non-GAAP base business core revenue growth in the high-single-digit percent range.
  • Price Action: DHR shares are down 0.73% at $256.00 during the premarket session on the last check Thursday.
  • Photo Via Company
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsLarge CapNewsGuidanceHealth CareMoversTrading IdeasGeneralBriefs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...